Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Rubin

Showing results (21-30 of 460) with videos related to

Pageof 46
Sort By:
Nature Cell Biology|January 9, 2021
Prostate cancer hijacks the microenvironmentPhillip Thienger, Mark A Rubin
Nature Medicine|January 6, 2026
Going beyond genomics in precision oncologyIrene Paassen, Mark A Rubin
The Prostate|June 3, 2022
The evolving landscape of prostate cancer somatic mutationsKellie Cotter, Mark A Rubin
European Urology|October 1, 2016
Re: Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical ProstatectomyArnauld Villers, Mark A Rubin
Cancer Cell|September 2, 2022
Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the futureDilara Akhoundova, Mark A Rubin
Journal of Cellular Biochemistry|February 3, 2004
Effect of finasteride on risk of prostate cancer: how little we really knowMark A Rubin, Philip W Kantoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancerMatthias D Hofer, Mark A Rubin
Urology|February 15, 2005
Benign positive margins after radical prostatectomy means a poor prognosis--conMark A Rubin, James E Montie
Nature|August 26, 2018
Sequence of events in prostate cancerKellie A Cotter, Mark A Rubin
Cancer Letters|September 8, 2022
Lineage plasticity in prostate cancer: Looking beyond intrinsic alterationsAlison M Ferguson, Mark A Rubin
Pageof 46

Showing results (21-30 of 460) with videos related to

Sort By:
Pageof 46
Nature Cell Biology|January 9, 2021
Prostate cancer hijacks the microenvironmentPhillip Thienger, Mark A Rubin
Nature Medicine|January 6, 2026
Going beyond genomics in precision oncologyIrene Paassen, Mark A Rubin
The Prostate|June 3, 2022
The evolving landscape of prostate cancer somatic mutationsKellie Cotter, Mark A Rubin
European Urology|October 1, 2016
Re: Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical ProstatectomyArnauld Villers, Mark A Rubin
Cancer Cell|September 2, 2022
Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the futureDilara Akhoundova, Mark A Rubin
Journal of Cellular Biochemistry|February 3, 2004
Effect of finasteride on risk of prostate cancer: how little we really knowMark A Rubin, Philip W Kantoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancerMatthias D Hofer, Mark A Rubin
Urology|February 15, 2005
Benign positive margins after radical prostatectomy means a poor prognosis--conMark A Rubin, James E Montie
Nature|August 26, 2018
Sequence of events in prostate cancerKellie A Cotter, Mark A Rubin
Cancer Letters|September 8, 2022
Lineage plasticity in prostate cancer: Looking beyond intrinsic alterationsAlison M Ferguson, Mark A Rubin
Pageof 46